ArticleFrontiers in cardiovascular medicine2023

Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction.

Juan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.